Pharmas back Accent’s plan to make RNA-targeting cancer drugs
Jan 23, 2024 · Accent Therapeutics has raised a $75 million Series C round, the company announced Tuesday in a sign of continued investor interest in chemical drugs that target RNA …
OFF
Pharmas Back Accent’s Plan To Make RNA-targeting Cancer Drugs
6 days from now
Jan 23, 2024 · Accent Therapeutics has raised a $75 million Series C round, the company announced Tuesday in a sign of continued investor interest in chemical drugs that target RNA …
biopharmadive.com
OFF
AstraZeneca Puts $55M Into Accent As Pharmas Continue Push To …
6 days from now
Jun 4, 2020 · A 2018 paper published in Nature Reviews Drug Discovery — co-authored by Accent president and chief scientific officer Bob Copeland — highlights some of the RNA …
biopharmadive.com
OFF
News - Capital Life Science – Mirae Asset
6 days from now
Accent Therapeutics | October 24, 2024. ... Two more pharmas practice their Accent, invest in $75M series C round. Fierce Biotech ... Endpoints News | January 23, 2024. Pharmas back …
miraeasset.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
